We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Use of the CamAPS FX hybrid closed-loop system improved ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Data were derived from Ebekozien O, et al. OP 020.
Canada: Researchers have reported that a closed-loop insulin delivery system significantly improves glucose control during ...
MONTPELLIER, France — Would closed-loop systems be a good option for young patients with type 1 diabetes? International and French recommendations on closed-loop systems state that the use of an ...
Even patients with type 2 diabetes can benefit from using a fully closed-loop insulin delivery system, also known as an artificial pancreas, according to an open-label crossover trial. In the ...
Young children using the t:slim X2 insulin pump with Control-IQ Technology system maintained target glucose levels for 3 hours longer than children using an insulin pump or daily injections with a ...
Compared with standard care, a closed-loop insulin delivery system increased the time spent within the pregnancy-specific glucose target range between 16 and 34 weeks 6 days ’ gestation among pregnant ...
Pediatric and adult Type 1 diabetes patients receiving a hybrid closed-loop artificial pancreas therapy demonstrated improved glucose control and lower risk of hypoglycemia compared to those managing ...
The National Institute for Health and Care Excellence (NICE), England’s cost-effectiveness watchdog, has finalized a draft guidance regarding hybrid closed-loop systems, concluding that the technology ...
Welcome to the era of algorithm-driven diabetes management, where closed-loop glucose monitoring systems keep you from tanking into hypoglycemic coma (although they seem to have a quirky preference ...
Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App
Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App: a strategic ...
People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With open-loop therapies*, insulin administration is manually controlled, while hybrid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results